(Total Views: 581)
Posted On: 02/10/2021 1:46:26 PM
Post# of 153902
Of the comments below, "any day now" is the most reasonable as per the latest PR which states "CytoDyn completed enrollment of 390 patients in its Phase 2b/3 randomized clinical trial for the severe-to-critically ill COVID-19 population and expects to release results in early February 2021."
Mostly comments that say “over due” , “ any day now”, or “ late” . I would ask you how you are qualifying your assumptions
Read More: https://investorshangout.com/post/newpost/605...z6m5ygqwLJ
Mostly comments that say “over due” , “ any day now”, or “ late” . I would ask you how you are qualifying your assumptions
Read More: https://investorshangout.com/post/newpost/605...z6m5ygqwLJ
(2)
(0)
